|
THE PHARMA REVIEW
(JAN 2010) |
The OPPI: A Soldier of
Indian Pharma Marketing and Research
|
|
Jeetu Gangil, Sanghmitra
Gautam, Dr Kishore, Girish Thunga |
|
Introduction: The Organization of
Pharmaceutical Producers of India (OPPI) established in
1965. It is a leading organization of pharmaceutical
manufactures in India. Mission of this organization is
to serve the collective interests of the members
professionally so as to make sure a healthy environment
for commercial growth of pharmaceutical market. Its
membership consists of companies with international
collaboration and many Indian pharmaceutical companies.
It represents mostly research based companies in India.
It organizes national and international seminars and
workshops relating to key issues of the pharmaceutical
business and healthcare. It supports scientific research
by professional and academic institutes. All OPPI
members adhere to the Code of Pharmaceutical Marketing
Practices of International Federation of Pharmaceutical
Manufacturers & Associations (IFPMA). OPPI has developed
the code for its members on the basis of IFPMA Code of
Pharmaceutical Marketing Practices. OPPI is an active
member of IFPMA, Geneva, and the World Self-Medication
Industry (WSMI) France. OPPI is actively engaged in
designing and conducting training programmes for
managers working in the Pharmaceutical Industry to
furnish them for competing in the global setting. OPPI
identifies itself with the country’s national objectives
in health and encourages its members to make significant
contributions to social concerns and actively promotes
Corporate Social Responsibility (CSR).
International Federation of Pharmaceutical
Manufacturers & Associations (IFPMA)
The International Federation of Pharmaceutical
Manufacturers & Associations (IFPMA) is a non-profit,
non-governmental Organization (NGO) representing
national industry associations and company of developing
countries. Member of the IFPMA are research-based
pharmaceutical, biotech and vaccine companies. In the
research and development pipeline, the pharmaceutical
industry is working on more than 700 new medicines and
vaccines for infectious diseases including HIV, AIDS,
cancer, heart disease and stroke and The main objectives
of IFPMA is to encourage a worldwide policy environment
that is encouraging to innovation in medicine, both
therapeutic and preventative for the benefit of patients
around the world.
For full text of this article contact the publisher on
info@kppub.com
|
|
Go to Content Index Page
|
|
The above content is an
abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate,
New Delhi, India -110016
Tel.: 26855839, 20057149, Fax: 91-11-26855876
Email:
info@kppub.com /
fpc@vsnl.com, Website:
http://www.kppub.com |
|
|
|
